Overview
What is Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc?
The Industry Pharmacogenomics Working Group, affiliated with Contreras Legal Strategy LLC, is a nonprofit organization situated in Washington, DC. Its primary objective is to enhance patient care by incorporating pharmacogenomics into drug development processes. The group achieves this by disseminating relevant information and sponsoring educational events, aiming to foster a broader public comprehension of pharmacogenomic research. Regular monthly teleconferences and annual face-to-face meetings are part of their strategy to engage and collaborate with relevant stakeholders in this field.
Official website here: www.i-pwg.org
Is Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc legitimate?
Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Official website here: www.i-pwg.org
What is the mission statement of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc?
The Industry Pharmacogenomics Working Group, affiliated with Contreras Legal Strategy LLC, is dedicated to enhancing patient care by incorporating pharmacogenomics into drug development. They strive to disseminate information and sponsor educational and informational programs to foster a broader public comprehension of pharmacogenomic research. The group regularly conducts monthly teleconferences and convenes for face-to-face meetings annually, promoting a collaborative approach to advancements in this field.
Official website here: www.i-pwg.org
Who is the CEO of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc?
Unavailable
Official website here: www.i-pwg.org
What is the revenue of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc?
Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc's revenue in 2022 was $79,952.
Official website here: www.i-pwg.org
Who are the executives of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc and what are their salaries?
Here are 3 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.i-pwg.org
Where can I find the form 990EZ for Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc?
Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc's most recent form 990EZ was submitted in 2022 and can be accessed here.
Official website here: www.i-pwg.org
Learn more at the official website: www.i-pwg.org
Mission Statement of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc
The Industry Pharmacogenomics Working Group, a renowned organization, is committed to enhancing patient care by incorporating pharmacogenomics into the drug development process. Their mission is twofold: firstly, they aim to disseminate information and sponsor educational and informational programs that foster a broader public understanding of pharmacogenomic research. Secondly, they strive to promote the integration of pharmacogenomics in drug development, ultimately aiming to improve patient outcomes. The group achieves these objectives through regular monthly teleconferences and annual face-to-face meetings, providing a platform for discussion and collaboration within the pharmacogenomics community.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Industry Pharmacogenomics Working Group significantly contributes to the enhancement of patient care by advocating for the integration of pharmacogenomics in drug development. By providing vital information and sponsoring educational programs, the group fosters a greater public understanding of pharmacogenomic research, which has the potential to personalize and optimize medical treatments for patients based on their genetic profiles.
Through regular teleconferences and annual face-to-face meetings, the Working Group facilitates collaboration among industry stakeholders, policymakers, and researchers, promoting dialogue and knowledge sharing. This initiative not only educates the community but also influences the practice of medicine by highlighting the importance of genetic factors in drug response. Overall, their efforts help pave the way for advancements in customized healthcare, ultimately resulting in better therapeutic outcomes and improved quality of life for patients.
This information is meant to be a general summary of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $79,952
Assets and Liabilities:
- Total Assets: $230,874
- Total Liabilities: $0
- Net Assets: $230,874
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Main Address
1711 MASSACHUSETTS AVENUE 710, WASHINGTON, DC, 20038
Website
www.i-pwg.orgNTEE Category
Code: S41 - Community improvement
If you are a representative of Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy Llc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.